SCHEMBL25525199

SCHEMBL25525199

COc1cc(Sc2ccccc2)cc(OC)c1C(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39
SLC6A4 P31645 1/20 0.39
TUBB4A P04350 5/20 0.38
TUBB P07437 5/20 0.38
TUBA3C P0DPH7 5/20 0.38
TUBA1B P68363 5/20 0.38
TUBA4A P68366 5/20 0.38
TUBB4B P68371 5/20 0.38
TUBB3 Q13509 5/20 0.38
TUBB2A Q13885 5/20 0.38
TUBB8 Q3ZCM7 5/20 0.38
TUBA3E Q6PEY2 5/20 0.38
TUBA1A Q71U36 5/20 0.38
TUBA1C Q9BQE3 5/20 0.38
TUBB6 Q9BUF5 5/20 0.38
TUBB2B Q9BVA1 5/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25525197 0.78 EP300 (0.44) HTR6L3MBTL1TDP1ALDH1A1MAPT
SCHEMBL25525198 0.78 HTR6 (0.44) HTR6L3MBTL1TDP1ALDH1A1MAPT
SCHEMBL11662398 0.76 TDP1 (0.51) HTR6L3MBTL1TDP1ALDH1A1MAPT
SCHEMBL25204814 0.74 AHR (0.53) ALDH1A1SLC6A4PTPN1CDC25ACDC25B
SCHEMBL25186864 0.73 LTA4H (0.50) HTR6L3MBTL1ALDH1A1MAPTCA12
SCHEMBL29014115 0.71 ALOX5 (0.50) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL919000 0.71 TUBB1 (0.66) ALDH1A1MAPTTUBB4ATUBBTUBA3C
SCHEMBL918999 0.71 TUBB1 (0.66) ALDH1A1MAPTTUBB4ATUBBTUBA3C
Diphenylsulfane SCHEMBL28510405 0.71 ALDH1A1 (0.50) HTR6ALDH1A1MAPTSLC6A4TUBB4A
SCHEMBL9814047 0.69 KDM4E (0.53) L3MBTL1TDP1ALDH1A1MAPTCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250136556-A1 NOVEL MODULATORS OF THE ARYL HYDROCARBON RECEPTOR AND METHODS OF USE THEREOF ALLIANTHERA BOSTON INC. 2025-05-01 US disclosed
CN-118748992-A Novel modulators of aryl hydrocarbon receptors and methods of use thereof 元启(苏州)生物制药有限公司 2024-10-08 CN disclosed
EP-4430028-A2 NOVEL MODULATORS OF THE ARYL HYDROCARBON RECEPTOR AND METHODS OF USE THEREOF Allianthera (Suzhou) Biopharmaceutical Co., Ltd. (CN) 2024-09-18 EP disclosed
WO-2023086428-A2 NOVEL MODULATORS OF THE ARYL HYDROCARBON RECEPTOR AND METHODS OF USE THEREOF ALLIANTHERA (SUZHOU) BIOPHARMACEUTICAL CO., LTD. (CN) 2023-05-19 WO disclosed
WO-2023086428-A2 NOVEL MODULATORS OF THE ARYL HYDROCARBON RECEPTOR AND METHODS OF USE THEREOF ALLIANTHERA (SUZHOU) BIOPHARMACEUTICAL CO., LTD. (CN) 2023-05-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250136556-A1 NOVEL MODULATORS OF THE ARYL HYDROCARBON RECEPTOR AND METHODS OF USE THEREOF AHR, ARNT, NR1H2 HTR6 112/4885L3MBTL1 4012/4885TDP1 3575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.